On May 16, MD LEG passed bill on right to try investigational drugs.
MD LEG passed HB 676, the Right to try act, relating to individualized investigational treatments of drugs, biological products, or devices; amends MD LEG 21-2B-01 et seq.
Provisions
Authorizes activity by manufacturers of investigational drugs, biological products, or devices to apply to manufacturers of certain individualized investigational treatments.
Also alters definition of eligible patient to include individuals with life-threatening or severely debilitating illnesses, rather than limiting term to those with terminal illness.
Authorizes health insurance carriers, third–party administrators, government agencies to provide coverage for the cost of certain investigational treatments and services.
Legislative History
On Jan. 25, 2024, bill introduced in House; on Mar. 13, 2024, bill passed House.
On Mar. 14, 2024, bill introduced in Senate; on Apr. 4, 2024, bill passed Senate.
On May 16, 2024, HB0676 approved by governor, designated as Chapter 960.
Effectiveness
Bill is effective on Oct. 1, 2024.
Regulators
MD LEG
Entity Types
Ins
Reference
Ch 960, Bill HB0676, 5/16/2024; Citation: MD LEG 21-2B-01;
